article thumbnail

Bile acids and the microbiome: revolutionising disease approaches

Drug Target Review

Biochemical Pharmacology. Gut Microbes. 2023 February 5 [2024 March 11]; 15(1). Available from: [link] 2 Biagoli M, Distrutti E, Fiorucci S, et al. Bile acids and bile activated receptors in the treatment of Covid-19. 2023 December 9 [2024 March 11] Available from: [link] 3 Abiead Y, Aiosa N, Antunes E, et al.

Disease 111
article thumbnail

Targeting the immunotherapy potential of cytokines IL-12 and IL-18 with new advancements in protein engineering

Drug Target Review

He is also a member of the Translator Scientific Advisory Committee at Harvard Medical School, an Associate Editor at Journal of Pharmacology and Experimental Therapeutics, a member of the Editorial Board at Biochemical Pharmacology and Fellow of the American Heart Association (Council for High Blood Pressure Research).

article thumbnail

Bivamelagon

New Drug Approvals

“Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors” Biochemical Pharmacology. .; Stewart, Gregory D.; Xu, Xiaomeng; Furness, Sebastian G.B. August 2022). 202 : 115115. doi : 10.1016/j.bcp.2022.115115. 2022.115115. PMID 35671790. S2CID 249452717.